MEGHAN LINDEN: Open Payments
NPI 1033424676 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$272 in 14 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $272
Food & beverage: $272
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 3 | $66 |
| ABBVIE INC. | 1 | $33 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: MOUNJARO, UBRELVY, APTIMA, ZEPBOUND, Jornay PM, EVENITY, GEMTESA, ImmunoCAP.
Industry payments across MO — which companies pay providers there.
